Arterial and venous thromboembolic disease in a patient with COVID-19: A case report

Autor: Bart Spaetgens, Hugo ten Cate, Hester A. Gietema, Renée A. G. Brüggemann, Coen D.A. Stehouwer, Borefore Jallah
Přispěvatelé: Biochemie, MUMC+: MA Med Staf Artsass Interne Geneeskunde (9), Beeldvorming, MUMC+: DA BV Medisch Specialisten Radiologie (9), RS: GROW - R3 - Innovative Cancer Diagnostics & Therapy, Interne Geneeskunde, MUMC+: HVC Trombosezorg (8), MUMC+: MA Alg Interne Geneeskunde (9), MUMC+: HVC Pieken Trombose (9), RS: Carim - B04 Clinical thrombosis and Haemostasis, MUMC+: HVC Pieken Maastricht Studie (9), MUMC+: MA Interne Geneeskunde (3), MUMC+: Centrum voor Chronische Zieken (3), MUMC+: MA Endocrinologie (9), MUMC+: MA Maag Darm Lever (9), MUMC+: MA Hematologie (9), MUMC+: MA Medische Oncologie (9), MUMC+: MA Nefrologie (9), MUMC+: MA Reumatologie (9), RS: Carim - V01 Vascular complications of diabetes and metabolic syndrome, RS: CAPHRI - R3 - Functioning, Participating and Rehabilitation
Jazyk: angličtina
Rok vydání: 2020
Předmět:
Zdroj: Thrombosis Research
Thrombosis Research, 191, 153-155. Elsevier Science
ISSN: 1879-2472
0049-3848
Popis: Highlights • Hypercoagulability is a major contributor to COVID-19 related pulmonary complications • Commonly used approaches may be insufficient to ameliorate the risk of thromboembolic events in patients with COVID-19 • Even when on thromboprophylaxis, it is crucial to remain vigilant for the occurrence of VTE in patients with COVID-19.
Databáze: OpenAIRE